Literature DB >> 3800461

Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery.

W M Mendenhall, R R Million, K I Bland, W W Pfaff, E M Copeland.   

Abstract

This is an analysis of 23 patients with clinically and/or surgically unresectable adenocarcinoma of the rectum on initial evaluation who were treated with preoperative irradiation and surgery between March 1970 and April 1981. All patients have had follow-up for at least 5 years. Five patients (22%) had exploratory laparotomy and diverting colostomy before irradiation. All patients were irradiated with megavoltage equipment to the pelvis at 180 rad/fraction, continuous-course technique. Total doses ranged from 3500 to 6000 rad with a mean of 4800 rad and a median of 5000 rad. All patients had surgery 2-11 weeks (mean: 4.9 weeks; median: 4 weeks) after radiation therapy. Twelve patients (52%) had lesions that were incompletely resected because of positive margins (7 patients), distant metastasis (1 patient), or both (4 patients). All of these patients died of cancer within 5 years of treatment. Eleven patients had an apparent complete excision of their rectal cancer; six patients (55%) subsequently had a local recurrence. The 5-year absolute survival rate for patients who had complete resection was 18% (2 of 11 patients). The 5-year absolute and determinate survival rates for the entire study were 9% (2 of 23 patients) and 9% (2 of 22 patients), respectively. One patient (in the incomplete resection group) died after operation secondary to sepsis and diffuse intravascular coagulation.

Entities:  

Mesh:

Year:  1987        PMID: 3800461      PMCID: PMC1492860          DOI: 10.1097/00000658-198701000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  Preoperative radiotherapy for adenocarcinoma of the rectosigmoid.

Authors:  K R Stevens; C V Allen; W S Fletcher
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  Radiotherapy in marginal resectable and non-resectable rectum cancer.

Authors:  A H Tierie
Journal:  Radiol Clin (Basel)       Date:  1978

Review 4.  Adjuvant radiation therapy for rectal adenocarcinoma.

Authors:  B J Cummings
Journal:  Dis Colon Rectum       Date:  1984-12       Impact factor: 4.585

5.  Elective ilioinguinal lymph node irradiation.

Authors:  R H Henderson; J T Parsons; L Morgan; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-06       Impact factor: 7.038

6.  Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum.

Authors:  W M Mendenhall; R R Million; K I Bland; W W Pfaff; E M Copeland
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

7.  Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas.

Authors:  D E Dosoretz; L L Gunderson; S Hedberg; B Hoskins; P H Blitzer; W Shipley; A Cohen
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

8.  Radiotherapy and resection for apparently inoperable rectal adenocarcinoma.

Authors:  O Mella; O Dahl; A Horn; I Morild; G Odland
Journal:  Dis Colon Rectum       Date:  1984-10       Impact factor: 4.585

9.  Effect of preoperative irradiation on resectability of colorectal carcinomas.

Authors:  B Emami; M Pilepich; C Willett; J E Munzenrider; H H Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-08       Impact factor: 7.038

10.  Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy.

Authors:  W M Mendenhall; R R Million; W W Pfaff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

View more
  8 in total

Review 1.  The role of intra-operative irradiation in locally advanced primary and recurrent rectal adenocarcinoma.

Authors:  L L Gunderson; M J O'Connell; R R Dozois
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.

Authors:  Stephanie Terezakis; Lisa Morikawa; Abraham Wu; Zhigang Zhang; Weiji Shi; Martin R Weiser; Philip B Paty; Jose Guillem; Larissa Temple; Garrett M Nash; Michael J Zelefsky; Karyn A Goodman
Journal:  Ann Surg Oncol       Date:  2015-01-29       Impact factor: 5.344

Review 3.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

4.  Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?

Authors:  W M Mendenhall; K I Bland; E M Copeland; G E Summers; W W Pfaff; W W Souba; R R Million
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

Review 5.  [Developments up to now and current status of adjuvant chemo- and radiotherapy in colonic and rectal carcinoma].

Authors:  T W Kraus; M J Eble; U Raeth
Journal:  Langenbecks Arch Chir       Date:  1994

6.  Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.

Authors:  A M Lowy; T A Rich; J M Skibber; R A Dubrow; S A Curley
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

Review 7.  Sphincter-saving procedures for distal carcinoma of the rectum.

Authors:  T J Yeatman; K I Bland
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

8.  Potential disadvantages of post-operative adjuvant radiotherapy after anterior resection for rectal cancer: a pilot study of sphincter function, rectal capacity and clinical outcome.

Authors:  W G Lewis; M E Williamson; A Kuzu; B M Stephenson; P J Holdsworth; P J Finan; D Ash; D Johnston
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.